The classical somatomedin hypothesis states that the IGFs mediate many of the physiologic functions of growth hormone (GH). Recently, however, it has become apparent that IGF physiology in the central nervous system differs significantly from that in the periphery as unique or variant IGF peptides, receptors and binding proteins have now been described in the CNS and CSF. A new somatomedin hypothesis is being proposed which suggests that the IGF network in the brain constitutes a distinct system in which the IGFs play important roles as neurohormones, neuromodulators and neurotransmitters. The goal of this proposal is to elucidate the unique biochemistry of the CNS IGF network and to study the role of IGFs in pituitary and CNS physiology. The two specific aims of the project are to address the following questions: I. What are the unique components of the CNS IGF Network?: CNS IGF and insulin receptors will be localized by immunohistochemistry, by in situ hybridization and by antireceptor antibodies. The novel CSF IGF binding protein will be purified and further characterized and the role of binding proteins in IGF action will be assessed. The hormonal regulation of IGF and insulin receptor and IGF binding protein synthesis will be determined in the rat. The concentration of IGF peptide will be correlated with IGF mRNA abundance, and the factors which alter translatability of the various mRNA transcripts will be studies. The role of local production of IGF-I and IGF-II will be determined. II. What are the effects of in vitro and in vivo IGF-I and IGF-II administration on the regulation of the hypothalamic-pituitary-IGF axes? The role of IGF-I and IGF-II in the regulation of GH and ACTH will be studied in static and perifusion cultures. The effect of parenteral IGF-I and IGF-II on GH and IGF synthesis and secretion in the rat and human will be evaluated. The effect of IGF-I and IGF-II on brain IGF receptors and binding proteins will be examined. The acute and chronic effects of IGF administration on glucose homeostasis will be studied using the glucose clamp technique.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK036054-06
Application #
3234375
Study Section
Endocrinology Study Section (END)
Project Start
1986-04-01
Project End
1996-05-31
Budget Start
1993-06-01
Budget End
1994-05-31
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Li, Tao; Hu, Ji-Fan; Qiu, Xinwen et al. (2008) CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop. Mol Cell Biol 28:6473-82
Qiu, Xinwen; Vu, Thanh H; Lu, Qiucheng et al. (2008) A complex deoxyribonucleic acid looping configuration associated with the silencing of the maternal Igf2 allele. Mol Endocrinol 22:1476-88
Chen, Theresa L; Shen, Wen-Jun; Qiu, Xin-Wen et al. (2007) Generation of novel adipocyte monolayer cultures from embryonic stem cells. Stem Cells Dev 16:371-80
Ling, Jian Qun; Hoffman, Andrew R (2007) Epigenetics of long-range chromatin interactions. Pediatr Res 61:11R-16R
Ling, Jian Qun; Li, Tao; Hu, Ji Fan et al. (2006) CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 312:269-72
Hoffman, Andrew R; Hu, Ji Fan (2006) Directing DNA methylation to inhibit gene expression. Cell Mol Neurobiol 26:425-38
Chen, Hui Ling; Li, Tao; Qiu, Xin Wen et al. (2006) Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. EMBO J 25:5329-38
Li, Tao; Vu, Thanh H; Ulaner, Gary A et al. (2005) IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Mol Hum Reprod 11:631-40
Vu, Thanh H; Li, Tao; Hoffman, Andrew R (2004) Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse. Hum Mol Genet 13:2233-45
Vu, Thanh H; Chuyen, Nguyen V; Li, Tao et al. (2003) Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Cancer Res 63:1900-5

Showing the most recent 10 out of 87 publications